5E Advanced Materials Provides Organizational Update
HESPERIA, Calif., June 04, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), […]
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
SUNNYVALE, Calif., June 04, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical […]
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product
PRINCETON, N.J., June 04, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing […]
Mobilicom CEO Oren Elkayam to Advocate for Uncrewed Systems at AUVSI’s Hill Day in Washington, D.C.
Elkayam joins other industry leaders in Washington, D.C. to champion regulations supportive of the growth of autonomous technologies Mobilicom to […]
Creative Realities to Be Included in Russell Microcap Index
LOUISVILLE, Ky., June 04, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities”, “CRI”, or the “Company”) (NASDAQ: CREX), a […]
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
Single Infusion of ANX005 30 mg/kg Met Primary Endpoint, Delivering a Highly Statistically Significant and Clinically Meaningful 2.4-fold Improvement in […]
Breckenridge Brewery Announces ‘On Tap with KBCO’ Concert Series Featuring Gary Clark Jr.
Tickets Available Now and Through June 10th LITTLETON, Colo., June 04, 2024 (GLOBE NEWSWIRE) — Breckenridge Brewery (“Breck Brew”), a […]
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) — Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data […]
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced […]
